Zusammenfassung
Ca. 0,2–1,5% aller malignen Tumoren; ca. 20% aller mediastinalen Tumoren und ca. 50% der Tumoren im vorderen oberen Mediastinum. Altersgipfel um das 50. Lebensjahr ohne eindeutige Geschlechtsprädilektion.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Verley J, Hollmann K (1985) Thymoma — A comparative study of clinical stages, histologic features, and survival in 200 cases. Cancer 55: 1974–1086
Batata M, Martini N, Huvos A, Aguilar R, Beattie E (1974) Thymomas, Clinicopathologic features, therapy, and prognosis. Cancer 34: 389–396
LeGolvan D, Abell M (1977) Thymomas. Cancer 39:2142— 2157
Rosai J, Levine GD (1976) Tumors of the thymus. Atlas of tumor pathology 2nd series. Washington DC: Armed Forces Institute of Pathology, S 34–153
Nakahara K, Ohno K, Hashimoto J, Maeda H, Miyoshi S, Sakurai M, Monden Y, Kawashima Y (1988) Thymoma: Results with complete resection and adjuvant irradiation in 141 consecutive patients. J Thorac Cardiovasc Surg 95: 1041–1047
Maggi G, Giaccone G, Donadio M, Ciuffreda L, Dalesio O, Leria G, Trifiletti G, Casadio C, Palestro G, Manusco M, Calciati A (1986) Thymoma — A review of 169 cases, with particular reference to results of surgical treatment. Cancer 58: 765–776
Maggi G, Casadio C, Cavallo A, Cianci R, Molinatti M, Ruffini E (1991) Thymoma: Results of 241 operated cases. Ann Thorac Surg 51: 152–156
Bergh NP, Gatzinsky P, Larsson S (1981) Tumors of the thymus and thymic region: I. Clinocopathological studies of thymomas. Ann Thorac Surg 25: 91–99
Sellors TH, Thackray AC, Thomson AD (1967) Tumors of the thymus. Thorax 22: 193–221
Wang L, Huang M, Lin T, Huang B, Vjien K (1992) Malignant thymoma. Cancer 70: 443–450
Marino M, Müller-Hermelink H (1985) Thymoma and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus. Virchows Arch [Pathol Anat] 407: 119–149
Kirchner T, Schalke B, Buchwald J, Ritter M, Marx A, Müller-Hermelink H (1992) Well-differentiated thymic carcinoma. An organotypical low-grade carcinoma with relationship to cortical thymoma. Am J Surg Pathol 16: 1153–1169
Quintanilla-Martinez L, Wilkins E, Choi N, Efird J, Hug E, Harris N (1994) Thymoma. Histologic subclassification is an independent prognostic factor. Cancer 74: 606–617
Pescarmona E, Rendina E, Venuta F, Ricci C, Ruco L, Baroni C (1990) The prognostic implication of thymoma histologic subtyping. A study of 80 consecutive cases. Am J Clin Pathol 93: 190–195
Kuo T, Lo S (1993) Thymoma: A study of the pathologic classification of 71 cases with evaluation of the Müller-Hermelink system. Hum Pathol 24: 766–771
Arrigada R, Bretel J, Caillaud J, Garreta L, Guerin R, Laugier A, Le Chevallier T, Schlienger M (1984) Invasive Carcinoma of the Thymus. A multicenter retrospective review of 56 cases. Eur J Cancer Clin Oncol 20: 69–74
Masaoka A, Monden Y, Nakahara K, Tanioka T (1981) Follow-up study of thymomas with special reference to their clinical stages. Cancer 48: 2485–2492
Urgesi A, Monetti U, Rossi G, Ricardi G, Ricardi U, Casadio C (1990) Role of radiation therapy in locally advanced thymoma. Radiother Oncol 19: 273–280
Souadjian W, Enrequez P, Siverstein MN (1974) The spectrum of diseases associated with thymoma. Arch Intern Med 134: 374–381
Pollack A, Komaki R, Cox J, Ro J, Oswald M, Shin D, Putnam J (1992) Thymoma: Treatment and prognosis. Int J Radiation Oncology Biol Phys 23: 1037–1043
Monden Y, Nakahara K, Iioka S, Nanjo S, Ohno K, Fujii Y, Hashimoto J, Kitagawa Y, Masaoka A, Kawashima Y (1985) Recurrence of thymoma: Clinicopathological features, therapy, and prognosis. Ann Thorac Surg 39: 165–169
Ariaratnam LS, Kalnicki S, Mincer F (1979) The management of malignant thymoma with radiaton therapy. Int J Radiat Oncol Biol Phys 5: 77–80
Curran W, Kornstein M, Brooks J, Turrisi A (1988) Invasive thymoma: The role of the mediastinal irradiation following complete or incomplete surgical resection. J Clin Oncol6: 1722–1727
Krueger J, Sagerman R, King G (1988) Stage III thymoma: Results of postoperative radiation therapy. Radiology 168: 855–858
Kersh C, Eisert D, Hazra T (1985) Malignant thymoma: Role of radiation therapy in management. Radiology 156: 207–209
Ciernik I, Meier U, Liftoff’ U (1994) Prognostic factors and outcome of incompletely resected invasive thymoma following radiation therapy. J Clin Oncol 12: 1484–1490
Cohen D, Ronnigen L, Graeber G, Deshong J, Jaffin J, Burge J, Zajtchuk R (1984) Management of patients with malignant thymoma. J Thorac Cardiovasc Surg 87: 301–307
Loehrer P (1993) Thymomas. Current experience and future directions in therapy. Drugs 45: 477–487
Hu E, Levine J (1986) Chemotherapy of malignant thymoma — Case report and review of the literature. Cancer 57: 1101–1104
Harper P, Highley M, Rankin E, Dussek J, Bryant B (1991) Ifosfamide mono-therapy demonstrates high activity in malignant thymoma. Proc Amer Soc Clin Oncol 10: 1049
Shellito J, Khandekar J, McKeever W, Vick N (1978) Invasive thymoma responsive to oral corticosteroids. Cancer Treat Rep 62: 1397–1400
Tandan R, Taylor R, DiCostanzo D, Sharma K, Fries T, Roberts J (1990) Metastasizing thymoma and myastenia gravis. Favorable response to glucocorticoids after failed chemotherapy and radiaton therapy. Cancer 65: 1286–1290
Kosmidis P, Iliopoulos E, Pentea S (1988) Combination chemotherapy with cyclophosphamide, adriamycin, and vincristine in malignant thymoma and myastenia gravis. Cancer 61: 1736–1740
Evans W, Thompson D, Simpson W, Feld R, Phillips M (1980) Combination chemotherapy in invasive thymoma — Role of COPP. Cancer 46: 1523–1527
Göldel N, Böning L, Frederik A, Hölzel D, Hartenstein R, Wilmanns W (1989) Chemotherapy of invasive thymoma. A restrospective study of 22 cases. Cancer 63: 1493–1500
Uematsu M, Kondo M (1986) A proposal for treatment of invasive thymoma. Cancer 58: 1979–1984
Chahinian A, Bhardwaj S, Meyer R, Jaffrey I, Kirschner P, Holland J (1981) Treatment of invasive or metastatic thymoma — Report of eleven cases. Cancer 47: 1752–1761
Dy C, Calvo F, Mindan J, Aparicio L, Algarra S, Gil A, Gonzalez F, Harguindey S (1988) Undifferentiated epithelial-rich invasive malignant thymoma: Complete response to cisplatin, vinblastine, and bleomycin therapy. J Clin Oncol 6: 536542
Fornasiero A, Daniele O, Ghiotto C, Piazza M, Fiore-Donati L, Calabro F, Rea F, Fiorentino M (1991) Chemotherapy for invasive thymoma — A 13-year experience. Cancer 68: 30–33
Loehrer P, Kim K, Aisner S, Livingston R, Einhorn L, Johnson D, Blum R (1994) Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: Final results of an Intergroup trial. J Clin Oncol 12: 1164–1168
Berruti A, Borasio P, Roncari A, Gorzegno G, Mossetti C, Dogliotti L (1993) Neoadjuvant chemotherapy with adriamycin, cisplatin, vincristin and cyclophosphamide (ADOC) in invasive thymomas: results in six patients. Ann Oncol 4: 429–431
Macchiarini P, Chella A, Ducci F, Rossi B, Testi C, Bevilacqua G, Angeletti C (1991) Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymoma. Cancer 68: 706–713
Berthaud P, LeChevalier T, Tursz T (1990) Effectiveness of interleukin-2 in invasive lymphoepithelial thymoma. Lancet 335: 1590
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schütte, J. (1995). Thymome. In: Seeber, S., Schütte, J. (eds) Therapiekonzepte Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10494-1_20
Download citation
DOI: https://doi.org/10.1007/978-3-662-10494-1_20
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-58586-2
Online ISBN: 978-3-662-10494-1
eBook Packages: Springer Book Archive